| 13th Sep 2006 11:44 am |
RNS |
Notice of Results |
| 22nd Aug 2006 7:01 am |
RNS |
Senior Management Appointment |
| 22nd Aug 2006 7:01 am |
RNS |
Clinical Update |
| 10th Aug 2006 7:00 am |
RNS |
Senior Appointment |
| 8th Aug 2006 7:01 am |
RNS |
Clinical Update |
| 22nd Jun 2006 7:02 am |
RNS |
In-Licence and Placing |
| 1st Jun 2006 7:01 am |
RNS |
Re Agreement |
| 27th Apr 2006 4:11 pm |
RNS |
Annual General Meeting |
| 6th Apr 2006 4:47 pm |
RNS |
Share Options Award |
| 4th Apr 2006 7:01 am |
RNS |
Prelim Results 31 Dec 05 |
| 16th Mar 2006 9:01 am |
RNS |
Notice of Results |
| 2nd Mar 2006 7:00 am |
RNS |
FDA Accept Phase II ( PSD597) |
| 21st Feb 2006 7:01 am |
RNS |
Licensing Agreement |
| 13th Feb 2006 1:27 pm |
RNS |
Holding(s) in Company |
| 10th Feb 2006 11:34 am |
RNS |
Result of EGM |
| 6th Feb 2006 11:25 am |
RNS |
Result of EGM |
| 3rd Feb 2006 5:30 pm |
RNS |
Holding(s) in Company |
| 31st Jan 2006 5:02 pm |
RNS |
Holding(s) in Company |
| 13th Jan 2006 7:30 am |
RNS |
Proposed Acq and Placing |
| 16th Dec 2005 7:00 am |
RNS |
PSD502 Final Clinical Data |
| 7th Dec 2005 11:23 am |
RNS |
Holding(s) in Company |
| 1st Dec 2005 7:00 am |
RNS |
PSD502 Clinical Trial Data |
| 30th Nov 2005 2:22 pm |
RNS |
Holding(s) in Company |
| 20th Oct 2005 7:00 am |
RNS |
Phase II Clinical Study |
| 26th Sep 2005 7:03 am |
RNS |
Interim Results |
| 26th Sep 2005 7:00 am |
RNS |
Product Acquisition |
| 12th Sep 2005 7:00 am |
RNS |
Phase II Clinical Trials |
| 31st Aug 2005 9:38 am |
RNS |
Notice of Results |
| 26th Jul 2005 7:00 am |
RNS |
Clinical Update |
| 13th Jul 2005 7:00 am |
RNS |
Collaborative Agreement |
| 30th Jun 2005 8:30 am |
RNS |
Share Options Award |
| 22nd Jun 2005 7:00 am |
RNS |
Clinical Update |
| 19th May 2005 7:00 am |
RNS |
Director Dealings |
| 28th Apr 2005 4:05 pm |
RNS |
Holding(s) in Company |
| 18th Apr 2005 7:00 am |
RNS |
Roche Announcement |
| 24th Mar 2005 8:00 am |
RNS |
First Day Dealings on AIM |
